VTI visioneering technologies inc.

parliment house launch

  1. 3,176 Posts.
    RNS Number:1528B
    Virotec International Ld
    23 July 2004


    22 July 2004


    Virotec Announces Official Launch of its HydroDec Technology


    The Directors of Virotec International Ltd (ASX/ AIM: VTI), are pleased to
    announce that the official launch of Virotec's new and exclusive HydroDecTM
    Technology will take place at Australia's Parliament House on 1 September 2004.



    HydroDecTM technology, developed over 12 years by the Australian CSIRO
    (Commonwealth Scientific & Industrial Research Organisation) in collaboration
    with Transgrid is being commercialised by Virotec under an exclusive licence
    agreement and the Directors believe it has great potential in the recycling of
    transformer oils. Its patented re-refining technology is able to efficiently
    re-refine used transformer oil, including PCB contaminated oils, to produce a
    new oil at a similar quality as traditional hydrotreatment refining processes.


    HydroDecTM technology has also been successfully applied to the destruction of a
    wide range of chlorinated hydrocarbons (PCB, DDT, PCP, HCB and dioxins) and a
    significant benefit of this process is that, unlike incineration, it makes the
    formation of dioxins totally impossible.


    Executive Chairman and CEO, Brian Sheeran explains "The Technology has no
    harmful emissions. To date we have committed approximately $1 Million to this
    project over 18 months and we are pleased to announce that a small HydroDecTM
    plant is now fully operational in Young, NSW Australia, processing transformer
    oil from Australian power utilities. To date the Company has secured orders with
    a value of approximately AUD$580,000."



    Virotec's exclusive global licence to commercialise HydroDecTM Technology has a
    term of 15 years or the life of the Intellectual Property, whichever is longer.
    In Australia, Virotec has entered into a Strategic partnership with Oil
    Treatment Services Pty Ltd for the purpose of establishing and operating
    HydroDecTM technology.



    Brian Sheeran expands "This is not Virotec's core business but we believe it is
    an exceptional opportunity that will definitely benefit Virotec shareholders.
    Virotec plans to expand the HydroDecTM business, domestically and
    internationally, and accordingly we are currently examining options on how we
    can maximise returns to Virotec shareholders whilst not interfering with our
    core business of marketing and implementing BauxsolTM Technology".


    This information is provided by RNS
    The company news service from the London Stock Exchange
    END
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.